Bill · S. 4066· Senate(119-S-4066)
Safeguarding Women from Chemical Abortion Act
- Introduced
- 3/11/2026
- Last activity
- 3/11/2026 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Josh Hawley
- Cosponsors
- - 7 - 0
- Introduced
- In Committee
What this bill would do
This bill is called the Safeguarding Women from Chemical Abortion Act. It withdraws the approved application for the drug mifepristone for the purpose of terminating an intrauterine pregnancy within 14 days of the bill's enactment. It makes introducing the withdrawn drug into interstate commerce a violation of the Federal Food, Drug, and Cosmetic Act. The bill also considers the drug misbranded if its labeling states it can be used to terminate an intrauterine pregnancy. Additionally, it establishes a Federal tort allowing women to sue drug manufacturers for bodily injury or mental health harm caused by chemical abortion drugs. Finally, the bill states it does not affect certain existing federal laws related to mailing obscene or crime-inciting matter.
Yes
Does this give the federal government more power?+5
The bill increases federal regulatory authority by withdrawing an FDA-approved drug via legislation and establishing a federal tort.
The opposite· 3 of 10
Does this make abortion easier to get?-10
The bill withdraws approval for the abortion medication mifepristone and bans its distribution for terminating pregnancies.
Would women be better off under this?-6
The bill bans a primary medication used for medical abortion, impacting women's healthcare access, though it creates a federal tort to sue manufacturers for harm.
Does this narrow the gap between how men and women are treated?-5
The bill restricts bodily autonomy and healthcare options specific to women.
Who it would affect, and how
Potential Positive Impacts for People
- Section 3(b) and Section 3(c): Women who suffer bodily injury or mental health harm attributable to the use of a covered medication can bring a civil action against the manufacturer to seek compensatory damages, punitive damages, and attorney's fees and costs. This provides a legal avenue for individuals to hold manufacturers accountable.
Potential Negative Impacts for People
-
Section 2(1): The bill deems the approved application for the drug mifepristone for the termination of intrauterine pregnancy to be withdrawn 14 days after enactment, which removes access to this specific medication for that purpose.
-
Section 2(2): Introducing or delivering the withdrawn drug into interstate commerce is considered a violation of the Federal Food, Drug, and Cosmetic Act, making it illegal to distribute the drug for this use.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Women-6Good For Business Owners-3Good For Young Adults-3Good For Low Income Households-2Good For Middle Aged-2
- Healthcare
- Improves Abortion Access-10Improves Healthcare Access-4
- Social Issues And Justice
- Improves Gender Equality-5
- Governance And Ideology
- Increases Federal Power+5Improves Privacy Rights-5Improves Interstate Commerce-3
- 6/23/2026
- 1 Cosponsor added.
- 4/20/2026
- 1 Cosponsor added.
- 4/15/2026
- 1 Cosponsor added.
- 3/25/2026
- 1 Cosponsor added.
- 3/23/2026
- 1 Cosponsor added.
- 3/18/2026
- 1 Cosponsor added.
- 3/12/2026
- 1 Cosponsor added.
- 3/11/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Marsha BlackburnRepublican · Tennessee
Ted BuddRepublican · North Carolina
John CornynRepublican · Texas
James LankfordRepublican · Oklahoma
Bernie MorenoRepublican · Ohio
Mike RoundsRepublican · South Dakota
Tommy TubervilleRepublican · Alabama